MedPath

Transcranial Magnetic Stimulation for Low Back Pain

Not Applicable
Withdrawn
Conditions
Chronic Low Back Pain
Interventions
Device: Transcranial Magnetic Stimulation
Registration Number
NCT02070016
Lead Sponsor
Stanford University
Brief Summary

The purpose of this study is to test whether non-invasive brain stimulation, such as Transcranial Magnetic Stimulation (TMS) may alleviate pain associated with various chronic pain conditions. We will test various methods of TMS to identify a treatment approach that may reduce the symptoms of chronic pain for the patient.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age 18 or older
  • Patient with Chronic Low Back Pain
  • Meets minimum pain level criteria
  • Ability to perform the experimental Task and Procedures
Read More
Exclusion Criteria
  • MRI contraindication if an MRI exam is required per protocol
  • TMS Contraindication
  • History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
  • Neurologic illness that would interfere with brain integrity
  • Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
  • Currently pregnant or planning to become pregnant.
  • On going legal action or disability claim.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
TMS Parameter Condition 2 FirstTranscranial Magnetic StimulationApplication of Transcranial Magnetic Stimulation
TMS Parameter Condition 1 firstTranscranial Magnetic StimulationApplication of Transcranial Magnetic Stimulation
Primary Outcome Measures
NameTimeMethod
Change in Average Daily PainBaseline Compared to each treatmeant series (at 4 weeks, 8 weeks, and 12 weeks)

Compared to baseline pain report as provided by Visual Analogue Scale (VAS)

Change in Worst Daily PainBaseline Compared to each treatment series (at 4 weeks, 8 weeks, and 12 weeks)

As compared to baseline worst daily pain report provided on visual analogue scale (VAS)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath